Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A deep learning algorithm developed using imaging data from more than 1,000 Alzheimer’s disease (AD) patients can accurately predict the presence of AD more than six years before a doctor finalizes a diagnosis, researchers reported in Radiology Nov. 6.
Researchers at the University of California, Los Angeles created a cheap, portable device that uses artificial intelligence (AI) to recognize and classify common airborne allergens.
NinePoint Medical, a Massachusetts-based medical device company, has received market clearance from the FDA for its new AI-based platform for image feature segmentation.
Medicare Advantage plans were allowed new flexibilities in 2019, but only a small number of plans will offer the additional supplemental benefits, according to AARP.
Researchers are hopeful a newly-developed machine-learning algorithm can be used to improve the detection of benign polyps during colonoscopies following a recent study validating the method.
Approximately 72,000 people died in the U.S. last year as a result of an opioid overdose. While Americans and lawmakers both agree that more needs to be done to improve the opioid abuse epidemic, the FDA approved yet another potent opioid on Nov. 2.
